Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Department of Pediatrics, Woman's & Children's University Hospital of Verona, 37126, Verona, Italy.
Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7.
Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.
在全球范围内，由严重急性呼吸系统综合症冠状病毒 2 型（SARS-CoV-2）引起的 2019 年冠状病毒病（COVID-19）引发了严重的公共卫生问题和重大的医学挑战。意大利儿科胃肠病学、肝病学和营养学学会（SIGENP）发表了多篇关于 COVID-19 对当前急性和慢性胃肠、肝、免疫介导和功能性疾病的管理、诊断和治疗的影响的论文。本文总结了 COVID-19 爆发期间和之后 SIGENP 的最相关报告和共识，包括炎症性肠病（IBD）的诊断和治疗、消化内镜的适应证和时机，以及对新型肝炎的见解。
